Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups
暂无分享,去创建一个
J Taylor | D. Bentley | E. Campo | J. Martín-Subero | R. Beekman | S. Knight | R. Houlston | Jenny C. Taylor | D. Vavoulis | R. Månsson | A. Schuh | J. Becq | A. Burns | R. Clifford | A. Timbs | B. Stamatopoulos | D. Bruce | P. Robbe | H. Dreau | R. Houlston | E Campo | R S Houlston | D Bentley | B Stamatopoulos | R Clifford | A Schuh | S J L Knight | A Burns | R Alsolami | J Becq | A Timbs | D Bruce | P Robbe | D Vavoulis | M Cabes | H Dreau | R Mansson | R Beekman | J I Martín-Subero | K E Ridout | R. Alsolami | K. Ridout | M. Cabes | J. Taylor | R. Månsson
[1] Axel Benner,et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. , 2008, Blood.
[2] Thomas Zichner,et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis , 2012, Bioinform..
[3] H. Döhner,et al. Treatment resistance in chronic lymphocytic leukemia–the role of the p53 pathway , 2009, Leukemia & lymphoma.
[4] T. Stankovic,et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia , 1999, The Lancet.
[5] L. Pasqualucci,et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. , 2011, Blood.
[6] Rob Pieters,et al. Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study , 2014 .
[7] W. Tapper,et al. Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease , 2016, Leukemia.
[8] Francesco Bertoni,et al. Genome‐wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion , 2008, British journal of haematology.
[9] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[10] A. Valencia,et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia , 2015, Nature.
[11] Paul T. Groth,et al. The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.
[12] H. Döhner,et al. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. , 1999, Blood.
[13] M. Stratton,et al. Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.
[14] E. Campo,et al. The genomic landscape of chronic lymphocytic leukemia: clinical implications , 2013, BMC Medicine.
[15] K. Ickstadt,et al. TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q , 2013, Haematologica.
[16] Steven J. M. Jones,et al. Recurrent targets of aberrant somatic hypermutation in lymphoma , 2012, Oncotarget.
[17] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[18] A Benner,et al. Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.
[19] Bing Li,et al. Histone H3 Methylation by Set2 Directs Deacetylation of Coding Regions by Rpd3S to Suppress Spurious Intragenic Transcription , 2005, Cell.
[20] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[21] David Botstein,et al. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.
[22] S. Swerdlow. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .
[23] Martin A. Nowak,et al. Mutations driving CLL and their evolution in progression and relapse , 2015, Nature.
[24] M. Minden,et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling , 2012, Nature.
[25] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[26] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[27] J. Michael Cherry,et al. Principles of metadata organization at the ENCODE data coordination center , 2016, Database J. Biol. Databases Curation.
[28] Semyon Kruglyak,et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms , 2013, Bioinform..
[29] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[30] A. Regev,et al. Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia , 2012, Clinical Cancer Research.
[31] Luca Laurenti,et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. , 2012, Blood.
[32] S. Gabriel,et al. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution , 2015, Nature Communications.
[33] Xiao-Jie Yan,et al. IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions. , 2012, Blood.
[34] A. Pettitt,et al. TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations , 2010, Leukemia.
[35] J. Byrd,et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.
[36] D. Catovsky,et al. TCL1 is activated by chromosomal rearrangement or by hypomethylation , 2001, Genes, chromosomes & cancer.
[37] A. Sivachenko,et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.
[38] D Rizopoulos,et al. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study , 2016, Leukemia.
[39] L. Pasqualucci,et al. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. , 2014, Blood.
[40] D. Catovsky,et al. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial , 2016, Leukemia.
[41] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[42] A. Rebollo,et al. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications. , 2011, Blood.
[43] H. Döhner,et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. , 2005, Blood.
[44] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[45] K. Do,et al. Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab). , 2014, Blood.
[46] L. Larocca,et al. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome , 2012, British journal of haematology.
[47] O. Bernard,et al. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages. , 2010, Leukemia research.
[48] David C. Jones,et al. Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.
[49] L. Pasqualucci,et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. , 2011, Blood.
[50] Jenny Taylor,et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. , 2012, Blood.
[51] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[52] Y. Pekarsky,et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.
[53] Gordon Cook,et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma , 2014, Nature Communications.
[54] S. Robson,et al. Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation , 2010, Cell.
[55] L. Pasqualucci,et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation , 2011, The Journal of experimental medicine.
[56] P. Timpson. Faculty Opinions recommendation of The topography of mutational processes in breast cancer genomes. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[57] Xiaobo Song,et al. Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1 , 2014, PloS one.
[58] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[59] Michalis K. Titsias,et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. , 2014, Blood.
[60] E. Giné,et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.
[61] H. Döhner,et al. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial. , 2016, Blood.
[62] Y. Tu,et al. Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.
[63] L. Lopez,et al. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia , 2017, Leukemia.
[64] H. Döhner,et al. Risk stratification in chronic lymphocytic leukemia. , 2006, Seminars in oncology.
[65] N. Chiorazzi,et al. B cell receptor signaling in chronic lymphocytic leukemia. , 2013, Trends in immunology.
[66] Manolis Kellis,et al. ChromHMM: automating chromatin-state discovery and characterization , 2012, Nature Methods.
[67] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[68] Gouri Nanjangud,et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas , 2001, Nature.
[69] R. Dalla‐Favera,et al. Mutations of NOTCH 1 are an independent predictor of survival in chronic lymphocytic leukemia , 2012 .